000-23593 | 94-3221585 | |
(Commission File Number) | (IRS Employer Identification No.) |
12061 Bluemont Way, Reston, VA | 20190 | |
(Address of Principal Executive Offices) | (Zip Code) |
c | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
c | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
c | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
c | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01. | Financial Statements and Exhibits. |
Exhibit Number | Description | |
99.1 | Text of press release of VeriSign, Inc. issued on July 28, 2016. |
VERISIGN, INC. | ||||
Date: July 28, 2016 | By: | /s/ Thomas C. Indelicarto | ||
Thomas C. Indelicarto | ||||
Executive Vice President, General Counsel and Secretary |
Exhibit No. | Description | |
Exhibit 99.1 | Text of press release of VeriSign, Inc. issued on July 28, 2016. |
• | Verisign ended the second quarter with cash, cash equivalents and marketable securities of $1.9 billion, a decrease of $8 million from year-end 2015. |
• | Cash flow from operations was $161 million for the second quarter of 2016, compared with $175 million for the same quarter in 2015. |
• | Deferred revenues on June 30, 2016, totaled $988 million, an increase of $26 million from year-end 2015. |
• | During the second quarter, Verisign repurchased 1.7 million shares of its common stock for $150 million. At June 30, 2016, $766 million remained available and authorized under the current share repurchase program which has no expiration. |
• | For purposes of calculating diluted EPS, the second quarter diluted share count included 21.9 million shares related to subordinated convertible debentures, compared with 17.0 million shares for the same quarter in 2015. These represent diluted shares and not shares that have been issued. |
• | Verisign Registry Services added 0.78 million net new names during the second quarter, ending with 143.2 million .com and .net domain names in the domain name base, which represents a 7.3 percent increase over the base at the end of the second quarter in 2015. |
• | In the second quarter, Verisign processed 8.6 million new domain name registrations for .com and .net, as compared to 8.7 million for the same quarter in 2015. |
• | The final .com and .net renewal rate for the first quarter of 2016 was 74.4 percent compared with 73.4 percent for the same quarter in 2015. Renewal rates are not fully measurable until 45 days after the end of the quarter. |
• | Verisign announces an increase in the annual fee for a .net domain name registration from $7.46 to $8.20, effective Feb. 1, 2017, per its agreement with the Internet Corporation for Assigned Names and Numbers (ICANN). |
June 30, 2016 | December 31, 2015 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 170,966 | $ | 228,659 | |||
Marketable securities | 1,736,030 | 1,686,771 | |||||
Accounts receivable, net | 15,086 | 12,638 | |||||
Other current assets | 22,573 | 39,856 | |||||
Total current assets | 1,944,655 | 1,967,924 | |||||
Property and equipment, net | 277,942 | 295,570 | |||||
Goodwill | 52,527 | 52,527 | |||||
Deferred tax assets | 13,205 | 17,361 | |||||
Other long-term assets | 25,844 | 24,355 | |||||
Total long-term assets | 369,518 | 389,813 | |||||
Total assets | $ | 2,314,173 | $ | 2,357,737 | |||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||
Current liabilities: | |||||||
Accounts payable and accrued liabilities | $ | 144,361 | $ | 188,171 | |||
Deferred revenues | 699,456 | 680,483 | |||||
Subordinated convertible debentures, including contingent interest derivative | 632,308 | 634,326 | |||||
Total current liabilities | 1,476,125 | 1,502,980 | |||||
Long-term deferred revenues | 288,232 | 280,859 | |||||
Senior notes | 1,236,272 | 1,235,354 | |||||
Deferred tax liabilities | 326,112 | 294,194 | |||||
Other long-term tax liabilities | 114,762 | 114,797 | |||||
Total long-term liabilities | 1,965,378 | 1,925,204 | |||||
Total liabilities | 3,441,503 | 3,428,184 | |||||
Commitments and contingencies | |||||||
Stockholders’ deficit: | |||||||
Preferred stock—par value $.001 per share; Authorized shares: 5,000; Issued and outstanding shares: none | — | — | |||||
Common stock—par value $.001 per share; Authorized shares: 1,000,000; Issued shares:323,941 at June 30, 2016 and 322,990 at December 31, 2015; Outstanding shares:107,180 at June 30, 2016 and 110,072 at December 31, 2015 | 324 | 323 | |||||
Additional paid-in capital | 17,279,468 | 17,558,822 | |||||
Accumulated deficit | (18,404,933 | ) | (18,625,599 | ) | |||
Accumulated other comprehensive loss | (2,189 | ) | (3,993 | ) | |||
Total stockholders’ deficit | (1,127,330 | ) | (1,070,447 | ) | |||
Total liabilities and stockholders’ deficit | $ | 2,314,173 | $ | 2,357,737 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Revenues | $ | 286,466 | $ | 262,539 | $ | 568,342 | $ | 520,961 | |||||||
Costs and expenses: | |||||||||||||||
Cost of revenues | 48,753 | 48,221 | 99,335 | 96,574 | |||||||||||
Sales and marketing | 19,757 | 24,329 | 39,784 | 46,711 | |||||||||||
Research and development | 14,288 | 16,347 | 31,031 | 33,499 | |||||||||||
General and administrative | 27,401 | 24,677 | 55,158 | 50,975 | |||||||||||
Total costs and expenses | 110,199 | 113,574 | 225,308 | 227,759 | |||||||||||
Operating income | 176,267 | 148,965 | 343,034 | 293,202 | |||||||||||
Interest expense | (28,859 | ) | (28,503 | ) | (57,663 | ) | (50,520 | ) | |||||||
Non-operating income (loss), net | 1,709 | 3,201 | 4,830 | (2,354 | ) | ||||||||||
Income before income taxes | 149,117 | 123,663 | 290,201 | 240,328 | |||||||||||
Income tax expense | (35,907 | ) | (30,652 | ) | (69,535 | ) | (59,079 | ) | |||||||
Net income | 113,210 | 93,011 | 220,666 | 181,249 | |||||||||||
Realized foreign currency translation adjustments, included in net income | 85 | (291 | ) | 85 | (291 | ) | |||||||||
Unrealized gain on investments | 851 | 147 | 1,786 | 234 | |||||||||||
Realized gain on investments, included in net income | (1 | ) | (69 | ) | (67 | ) | (73 | ) | |||||||
Other comprehensive income (loss) | 935 | (213 | ) | 1,804 | (130 | ) | |||||||||
Comprehensive income | $ | 114,145 | $ | 92,798 | $ | 222,470 | $ | 181,119 | |||||||
Earnings per share: | |||||||||||||||
Basic | $ | 1.05 | $ | 0.80 | $ | 2.03 | $ | 1.56 | |||||||
Diluted | $ | 0.87 | $ | 0.70 | $ | 1.68 | $ | 1.36 | |||||||
Shares used to compute earnings per share | |||||||||||||||
Basic | 108,067 | 115,656 | 108,829 | 116,394 | |||||||||||
Diluted | 130,588 | 133,251 | 131,084 | 133,546 |
Six Months Ended June 30, | |||||||
2016 | 2015 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 220,666 | $ | 181,249 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation of property and equipment | 29,417 | 31,620 | |||||
Stock-based compensation | 22,891 | 22,129 | |||||
Excess tax benefit associated with stock-based compensation | (12,708 | ) | (11,366 | ) | |||
Unrealized (gain) loss on contingent interest derivative on Subordinated Convertible Debentures | (971 | ) | 4,311 | ||||
Payment of contingent interest | (6,544 | ) | (5,225 | ) | |||
Amortization of debt discount and issuance costs | 6,590 | 5,941 | |||||
Other, net | (1,414 | ) | (1,099 | ) | |||
Changes in operating assets and liabilities | |||||||
Accounts receivable | (2,798 | ) | (1,018 | ) | |||
Prepaid expenses and other assets | 15,430 | 7,369 | |||||
Accounts payable and accrued liabilities | (28,653 | ) | (4,778 | ) | |||
Deferred revenues | 26,346 | 41,247 | |||||
Net deferred income taxes and other long-term tax liabilities | 36,039 | 37,245 | |||||
Net cash provided by operating activities | 304,291 | 307,625 | |||||
Cash flows from investing activities: | |||||||
Proceeds from maturities and sales of marketable securities | 2,056,607 | 1,283,367 | |||||
Purchases of marketable securities | (2,101,863 | ) | (1,747,025 | ) | |||
Purchases of property and equipment | (13,458 | ) | (21,891 | ) | |||
Other investing activities | 206 | (3,736 | ) | ||||
Net cash used in investing activities | (58,508 | ) | (489,285 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from issuance of common stock from option exercises and employee stock purchase plans | 8,084 | 9,014 | |||||
Repurchases of common stock | (324,235 | ) | (335,885 | ) | |||
Proceeds from borrowings, net of issuance costs | — | 492,237 | |||||
Excess tax benefit associated with stock-based compensation | 12,708 | 11,366 | |||||
Net cash (used in) provided by financing activities | (303,443 | ) | 176,732 | ||||
Effect of exchange rate changes on cash and cash equivalents | (33 | ) | 606 | ||||
Net decrease in cash and cash equivalents | (57,693 | ) | (4,322 | ) | |||
Cash and cash equivalents at beginning of period | 228,659 | 191,608 | |||||
Cash and cash equivalents at end of period | $ | 170,966 | $ | 187,286 | |||
Supplemental cash flow disclosures: | |||||||
Cash paid for interest | $ | 57,636 | $ | 42,839 | |||
Cash paid for income taxes, net of refunds received | $ | 13,994 | $ | 14,342 |
Three Months Ended June 30, | |||||||||||||||
2016 | 2015 | ||||||||||||||
Operating Income | Net Income | Operating Income | Net Income | ||||||||||||
GAAP as reported | $ | 176,267 | $ | 113,210 | 148,965 | $ | 93,011 | ||||||||
Adjustments: | |||||||||||||||
Stock-based compensation | 11,132 | 11,132 | 12,001 | 12,001 | |||||||||||
Unrealized loss (gain) on contingent interest derivative on the subordinated convertible debentures | 94 | (2,708 | ) | ||||||||||||
Non-cash interest expense | 3,323 | 2,956 | |||||||||||||
Contingent interest payable on subordinated convertible debentures | (3,421 | ) | (2,767 | ) | |||||||||||
Tax adjustment | (5,758 | ) | (3,965 | ) | |||||||||||
Non-GAAP | $ | 187,399 | $ | 118,580 | $ | 160,966 | $ | 98,528 | |||||||
Revenues | $ | 286,466 | $ | 262,539 | |||||||||||
Non-GAAP operating margin | 65.4 | % | 61.3 | % | |||||||||||
Diluted shares | 130,588 | 133,251 | |||||||||||||
Diluted EPS, non-GAAP | $ | 0.91 | $ | 0.74 |
Six Months Ended June 30, | |||||||||||||||
2016 | 2015 | ||||||||||||||
Operating Income | Net Income | Operating Income | Net Income | ||||||||||||
GAAP as reported | $ | 343,034 | $ | 220,666 | 293,202 | $ | 181,249 | ||||||||
Adjustments: | |||||||||||||||
Stock-based compensation | 22,891 | 22,891 | 22,129 | 22,129 | |||||||||||
Unrealized (gain) loss on contingent interest derivative on the subordinated convertible debentures | (971 | ) | 4,311 | ||||||||||||
Non-cash interest expense | 6,590 | 5,662 | |||||||||||||
Contingent interest payable on subordinated convertible debentures | (6,767 | ) | (5,457 | ) | |||||||||||
Tax adjustment | (11,571 | ) | (10,334 | ) | |||||||||||
Non-GAAP | $ | 365,925 | $ | 230,838 | $ | 315,331 | $ | 197,560 | |||||||
Revenues | $ | 568,342 | $ | 520,961 | |||||||||||
Non-GAAP operating margin | 64.4 | % | 60.5 | % | |||||||||||
Diluted shares | 131,084 | 133,546 | |||||||||||||
Diluted EPS, non-GAAP | $ | 1.76 | $ | 1.48 |
Three Months Ended June 30, | |||||||
2016 | 2015 | ||||||
Net Income | $ | 113,210 | $ | 93,011 | |||
Interest expense | 28,859 | 28,503 | |||||
Income tax expense | 35,907 | 30,652 | |||||
Depreciation and amortization | 14,550 | 15,873 | |||||
Stock-based compensation | 11,132 | 12,001 | |||||
Unrealized loss (gain) on contingent interest derivative on the subordinated convertible debentures | 94 | (2,708 | ) | ||||
Unrealized (gain) loss on hedging agreements | (994 | ) | 944 | ||||
Non-GAAP Adjusted EBITDA | $ | 202,758 | $ | 178,276 |
Four Quarters Ended June 30, 2016 | |||
Net income | 414,653 | ||
Interest expense | 114,774 | ||
Income tax expense | 122,870 | ||
Depreciation and amortization | 59,288 | ||
Stock-based compensation | 46,837 | ||
Unrealized loss on contingent interest derivative on the subordinated convertible debentures | 8,848 | ||
Unrealized gain on hedging agreements | (825 | ) | |
Non-GAAP Adjusted EBITDA | $ | 766,445 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Cost of revenues | $ | 1,747 | $ | 1,741 | $ | 3,588 | $ | 3,480 | |||||||
Sales and marketing | 1,457 | 1,818 | 3,090 | 3,117 | |||||||||||
Research and development | 1,587 | 1,691 | 3,290 | 3,412 | |||||||||||
General and administrative | 6,341 | 6,751 | 12,923 | 12,120 | |||||||||||
Total stock-based compensation expense | $ | 11,132 | $ | 12,001 | $ | 22,891 | $ | 22,129 |